Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ArQule, Inc. (ARQL) -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (495)	4/23/2010 1:40:11 PM
From: scaram(o)uche	Read Replies (3) \| Respond to of 545

Yeah, figured out that it was the phase II data and the need for material disclosure before the meeting. Thanks!.... "Occasionally a publicly traded company is advised that it is legally required to disclose certain data or other information from a confidential abstract in advance of the public release date to satisfy requirements of the U.S. Securities and Exchange Commission or a corresponding regulatory body in a country where the company’s stock is traded (collectively, “SEC”). Generally this need arises when there is a substantial likelihood that the information would be considered by a reasonable investor in the company to have significantly altered the total mix of information made available to the investor."